Table 1 HPV DNA detection in 135 head and neck cancer cases from oral cavity (n = 45), nasopharynx (n = 9), oropharynx (n = 19), pharynx unspecified (n = 25) and larynx (n = 37) in Central African Republic, by patients’ characteristics during the period 2009 to 2017
Variables | Samples tested for HPV | HPV positive sample | ||
|---|---|---|---|---|
N | % | N | % (95% CI) | |
Gender | ||||
Male | 74 | 54.8 | 1a | 1.35 (0.0–3.9) |
Female | 61 | 45.2 | 0 | 0.0 (0.0–0.06)b |
Age at diagnosis (years) | ||||
≤39 | 27 | 20.0 | 0 | 0.0 (0.0–0.13)b |
40-49 | 17 | 12.6 | 0 | 0.0 (0.0–0.18)b |
50-59 | 15 | 11.1 | 1 | 6.67 (0.0–19.3) |
≥60 | 76 | 56.3 | 0 | 0.0 (0.0–0.05)b |
Period of diagnosis | ||||
2009–2011 | 32 | 23.7 | 0 | 0.0 (0.0–0.11)b |
2012-2014 | 64 | 47.4 | 1 | 1.56 (0.0–4.6) |
2015–2017 | 39 | 28.9 | 0 | 0.0 (0.0–0.09)b |
Histological type | ||||
Squamous cell carcinoma | 129 | 95.6 | 1 | 0.78 (0.0–2.3) |
Adenocarcinoma | 6 | 4.4 | 0 | 0.0 (0.0–0.39)b |